Bio-identical Hormone & Peptide Specialists

Table of Contents
Cardio Res-Q Assessment from $775

Advanced labs, the Cleveland Heart panel and Dr. Varano’s evaluation:

Low Testosterone and Heart Health: What the Evidence Shows

Low Testosterone and Heart Health: What the Evidence Shows

Low testosterone is linked with higher heart and metabolic risk in men, but a link is not a cause. In many men, low testosterone looks more like a sign of poorer overall health, such as excess weight or type 2 diabetes, than a driver of heart disease in its own right.

The largest safety trial so far found that testosterone therapy did not increase major cardiac events in men with confirmed low testosterone. It did not reduce them either. Testosterone therapy is a treatment for testosterone deficiency. It is not a heart treatment.

Key takeaways

  • Low testosterone is linked with higher heart risk, but it often looks like a sign of poorer overall health and not a proven cause.
  • In the largest trial, testosterone therapy neither raised nor lowered major cardiac events in men with confirmed low testosterone.
  • That trial also saw more atrial fibrillation, acute kidney injury and pulmonary embolism in the testosterone group.
  • Testosterone therapy treats the symptoms of deficiency and is not a way to prevent heart disease.
  • Erectile dysfunction can be an early vascular warning sign and makes a heart risk check reasonable.

What "low testosterone" actually means

Testosterone falls gradually with age, and levels swing through the day. A single low reading does not make a diagnosis.

The Endocrine Society's guideline recommends diagnosing testosterone deficiency, also called hypogonadism, only in men who have both consistent symptoms and unequivocally, consistently low levels. It recommends a fasting morning blood test, repeated to confirm the result.1

This matters for the heart question. Most of the research below is about men who met that stricter definition, not men with a borderline number and no symptoms.

What low testosterone is linked to

The strongest links are metabolic. In a pooled analysis of 43 studies, men with type 2 diabetes had clearly lower testosterone than men without it, and men with higher testosterone had a 42% lower risk of developing type 2 diabetes.2

Low testosterone also travels with excess abdominal fat, raised blood sugar and insulin resistance. Each of these raises heart risk through routes that have nothing to do with hormones.

There is a link with survival as well. A review of community studies found that men with low testosterone had a higher risk of death from any cause and from cardiovascular disease.

Why association is not causation

The same review added an important caution. Results varied widely from study to study, and the authors concluded that the effects were probably driven by differences in the men studied, such as their underlying health.3

That fits what is known about testosterone. Excess body fat, type 2 diabetes, poor sleep and long-term illness can all lower it. So a low level may be the result of the same conditions that damage arteries, with both pointing back to a shared cause.

Observational studies cannot settle this. Only a randomized trial can show whether raising testosterone changes heart outcomes.

What the TRAVERSE trial found

TRAVERSE, published in the New England Journal of Medicine in 2023, is the largest such trial. It enrolled 5,246 men aged 45 to 80 who had symptoms of hypogonadism, two fasting testosterone levels below 300 ng/dL, and either existing cardiovascular disease or a high risk of it. They were randomly assigned to a daily testosterone gel or a placebo gel.

OutcomeTestosteronePlacebo
Cardiovascular death, nonfatal heart attack or nonfatal stroke7.0% (182 men)7.3% (190 men)
Atrial fibrillation, acute kidney injury, pulmonary embolismHigher incidenceLower incidence

The trial was designed to test safety, and on its main measure testosterone was found to be noninferior to placebo. In plain terms, it did not raise the rate of major cardiac events. The researchers also reported a higher incidence of atrial fibrillation, acute kidney injury and pulmonary embolism in the testosterone group.4

Three limits are worth knowing:

  • The men had confirmed low testosterone with symptoms. The results do not apply to men with normal levels.
  • Treatment lasted about 22 months on average, with about 33 months of follow-up. Longer-term effects are less certain.
  • The trial tested one form of prescribed therapy, adjusted to keep blood levels in a set range. It says nothing about higher doses or unsupervised use.

Testosterone therapy is not a heart treatment

TRAVERSE answered a safety question. It did not show that testosterone prevents heart attacks or strokes, because the rates in the two groups were about the same.

The Endocrine Society recommends testosterone therapy for men with symptomatic deficiency, to correct those symptoms, after a discussion of benefits and risks. Lowering cardiovascular risk is not among the reasons it gives. It also recommends against starting it in men who have had a heart attack or stroke in the last six months, or who have uncontrolled heart failure, a raised red blood cell level or a tendency to form clots.1

If you have low testosterone and heart risk factors, they are two separate problems to work on. Blood pressure, cholesterol, blood sugar, weight, activity and smoking are still what determine your heart risk.

Erectile dysfunction as an early vascular warning

Men often look into testosterone because of erectile dysfunction, or ED. ED has its own relationship with the heart.

An erection depends on healthy blood vessels. In a pooled analysis of 12 prospective studies with 36,744 participants, men with ED had a 48% higher risk of cardiovascular disease, a 46% higher risk of coronary heart disease and a 35% higher risk of stroke than men without it. The authors judged the increase to be probably independent of standard risk factors.5

An expert panel on sexual function and heart health, known as the Princeton Consensus, highlights this link. It notes that cardiovascular disease in men with ED may be present without symptoms and may benefit from risk reduction.6

ED has many causes, including medicines, stress, nerve problems and hormones, and it does not mean you have heart disease. It does mean a heart risk check is reasonable, especially if ED appears in your 40s or 50s without an obvious reason. Our page on erectile dysfunction explains more.

Your next step

If you have low testosterone, ED or both, the sensible move is to find out where your heart risk stands on its own terms. Our guide to a heart disease risk assessment explains what a preventive evaluation looks at.

You can also answer the three quick questions in the screener on the Cardio Res-Q program page. Low testosterone and erectile dysfunction are both on the list of risk factors the program screens for. No testosterone or other hormone test is part of the first visit.

Cardiovascular Risk Screener

Are You a Candidate for Cardio Res-Q?

Three quick questions about the risk factors we screen for. Your answers stay between you and the clinic.

Frequently asked questions

Does low testosterone cause heart disease?

That has not been shown. Low testosterone is associated with diabetes, excess weight and higher death rates in population studies, but researchers believe much of this reflects underlying health and not a direct effect of the hormone. It is best treated as a prompt to check your other risk factors.

Is testosterone therapy safe for the heart?

In the TRAVERSE trial, men with confirmed hypogonadism who used testosterone gel had no more major cardiac events than men on placebo over about three years of follow-up. Atrial fibrillation, acute kidney injury and pulmonary embolism were more frequent with testosterone. Whether it is right for you depends on your own history and is a decision for you and your prescriber.

Will raising my testosterone lower my heart risk?

There is no good evidence that it will. The largest trial found similar rates of heart attack, stroke and cardiovascular death with testosterone and with placebo. Testosterone therapy treats the symptoms of deficiency. It is not a way to prevent heart disease.

Should a man with erectile dysfunction have his heart checked?

It is a reasonable step. Pooled studies show men with ED have a higher rate of later cardiovascular disease, and expert guidance notes that heart disease in these men can be silent. Tell your doctor about ED so that blood pressure, cholesterol and blood sugar can be reviewed.

Related reading

This article is for general education and is not medical advice. Decisions about testing and medication should be made with your clinician. If you have chest pain or other symptoms of a heart attack, call 911.

Optimize Your Health Today!

Cardio Res-Q starts with the $775 Comprehensive or $999 Enhanced Assessment, led by Dr. Varano.

age management doctor philadelphia
Send Us A Message
About Dr. Kenneth Varano, D.O.
age management doctor philadelphia

YoungerMeMD is a physician-led practice in Anti-Aging, Functional and Preventive Medicine, and your care is delivered by our whole clinical team. That team works under Medical Director Kenneth Varano, D.O., who brings over 30 years in clinical medicine and more than 20 years in age management and functional medicine — using science-backed, patient-focused strategies that restore balance, vitality, and health longevity.

About Barbara Dougherty
anti aging treatments

Barbara Dougherty, MSN, CRNP, is a Board-Certified Family Nurse Practitioner and Certified Menopause Practitioner (MSCP) specializing in optimizing hormones, and improving cardio-metabolic health. 

Read Our Reviews

“I’ve been seeing Dr. Varano for just over a year now, and I don’t think I’ve been this healthy and energetic since grade school.

Transform Your Health Today

Ready to take the first step toward renewed energy, balance, and longevity? New patients can register for an initial evaluation to begin their personalized anti-aging journey with YoungerMe MD. Live Younger. Better. Longer. — with YoungerMe MD.

References

  1. Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2018. PMID 29562364 · doi:10.1210/jc.2018-00229↩
  2. Ding EL, et al. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006. PMID 16537739 · doi:10.1001/jama.295.11.1288↩
  3. Araujo AB, et al. Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011. PMID 21816776 · doi:10.1210/jc.2011-1137↩
  4. Lincoff AM, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med 2023. PMID 37326322 · doi:10.1056/NEJMoa2215025↩
  5. Dong JY, et al. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol 2011. PMID 21920268 · doi:10.1016/j.jacc.2011.06.024↩
  6. Nehra A, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc 2012. PMID 22862865 · doi:10.1016/j.mayocp.2012.06.015↩
Book a Discovery Call Peptide Consult
Close
Book a Discovery Call
Close
Peptide Consult







    Transform Your
    Health & Wellness

    Fill up the form below to get started

      Provocation agent administered prior to timed urine collection (<6hr). Reveals toxic metal burden that can block hormone and peptide response.

      Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.

      DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.

      Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.

      Cardio Res-Q cardiac risk panel – inflammation markers and cardiovascular biomarkers beyond standard labs.

      Evaluates intracellular vitamin, mineral, and antioxidant status – foundational to optimizing cellular health and peptide efficacy.

      Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.

      Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.

      What It Evaluates

      Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:

      Conditions We Identify